MSD to strength R&D in Korea
Published: 2011-04-05 06:56:00
Updated: 2011-04-05 06:56:00
Merck& Co., a U.S.-based pharmaceutical company, plans to strengthen research and development (R&D) capability in Korea in cooperation with local research institutes to step up studies in the innovative drugs and vaccines.
The company’s Global Human Health President Adam H. Schechter and Korea...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
